3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
13
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Neoplasms
4
Lung Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Skin Diseases
2
Pancreatic Neoplasms
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Spinocerebellar Degenerations
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Soft Tissue Neoplasms
1
Peripheral Nervous System Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Noonan Syndrome 5
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Multiple Myeloma
1
Lymphoma
1
Lymphatic Metastasis
1
Low-grade Serous Ovarian Cancer
1
Leukemia, Myeloid, Acute
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Interventions
Sunitinib
16
Imatinib Mesylate
13
nilotinib
8
ripretinib
4
regorafenib
4
avapritinib
3
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
3
pexidartinib
2
pembrolizumab
2
Bevacizumab
2
trametinib
1
tinostamustine
1
spartalizumab
1
romidepsin
1
ponatinib
1
pazopanib
1
palbociclib
1
olaratumab
1
guadecitabine
1
ferric carboxymaltose
1
epacadostat
1
dabrafenib
1
cediranib
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sorafenib
1
STA 9090
1
Observation
1
Iron-Dextran Complex
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Stromal Tumors
×
binimetinib
×
Clear all
No trials found.